Agios Pharmaceuticals
IPOAgios
Public · Cambridge, United States · Founded 2007 · $241.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 501–1000
- Founded
- 2007
- Business Model
- B2B
- Website
- agios.com
- Total Funding
- $241.0M
- Last Round
- $78.0M Series CNov 2011
- Rounds
- 3
- Type
- Public
About
Agios is a commercial-stage biopharmaceutical company pioneering therapies for rare diseases through its leadership in cellular metabolism science. Its first FDA-approved therapy treats hemolytic anemia in adults with pyruvate kinase deficiency, and its lead pipeline candidate mitapivat is in late-stage trials for thalassemia and sickle cell disease. Agios also advances novel PK activators and multiple preclinical programs targeting rare hematologic conditions.
Summary
Agios Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2007. It has raised $241.0M in total across 3 rounds, most recently a $78.0M Series C round in Nov 2011. Investors include Public Investment Fund, Third Rock Ventures and ARCH Venture Partners.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jul 2013
Sign up to see all 4 rounds
Series A through IPO — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/agios-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/agios-pharmaceuticals" alt="Agios Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>